nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—Eplerenone—coronary artery disease	0.36	1	CrCtD
Medroxyprogesterone Acetate—ESR1—coronary artery disease	0.0943	1	CbGaD
Medroxyprogesterone Acetate—Drospirenone—Eplerenone—coronary artery disease	0.0289	0.138	CrCrCtD
Medroxyprogesterone Acetate—Spironolactone—Eplerenone—coronary artery disease	0.0276	0.131	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Eplerenone—coronary artery disease	0.0202	0.0963	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Eplerenone—coronary artery disease	0.0196	0.0933	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Eplerenone—coronary artery disease	0.0175	0.0832	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Eplerenone—coronary artery disease	0.017	0.0811	CrCrCtD
Medroxyprogesterone Acetate—Testosterone Propionate—Eplerenone—coronary artery disease	0.017	0.0811	CrCrCtD
Medroxyprogesterone Acetate—Progesterone—Eplerenone—coronary artery disease	0.017	0.0811	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Eplerenone—coronary artery disease	0.0166	0.079	CrCrCtD
Medroxyprogesterone Acetate—Testosterone—Eplerenone—coronary artery disease	0.0148	0.0704	CrCrCtD
Medroxyprogesterone Acetate—CYP2C8—Fenofibrate—coronary artery disease	0.0141	0.0762	CbGbCtD
Medroxyprogesterone Acetate—Hydrocortisone—Eplerenone—coronary artery disease	0.0139	0.0661	CrCrCtD
Medroxyprogesterone Acetate—CYP2C8—Gemfibrozil—coronary artery disease	0.0113	0.061	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Fenofibrate—coronary artery disease	0.00985	0.0532	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Clopidogrel—coronary artery disease	0.00979	0.0529	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Pitavastatin—coronary artery disease	0.00855	0.0462	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Gemfibrozil—coronary artery disease	0.00787	0.0425	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Clopidogrel—coronary artery disease	0.00683	0.0369	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Ticagrelor—coronary artery disease	0.00643	0.0347	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00615	0.0332	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Pitavastatin—coronary artery disease	0.00597	0.0322	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Simvastatin—coronary artery disease	0.00586	0.0317	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Valsartan—coronary artery disease	0.0058	0.0313	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Lovastatin—coronary artery disease	0.00574	0.031	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Pravastatin—coronary artery disease	0.00574	0.031	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Fenofibrate—coronary artery disease	0.00573	0.0309	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Atorvastatin—coronary artery disease	0.00523	0.0282	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Losartan—coronary artery disease	0.00478	0.0258	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Gemfibrozil—coronary artery disease	0.00458	0.0247	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Rosuvastatin—coronary artery disease	0.0044	0.0238	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00429	0.0231	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Simvastatin—coronary artery disease	0.00409	0.0221	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Lovastatin—coronary artery disease	0.004	0.0216	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Pravastatin—coronary artery disease	0.004	0.0216	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Clopidogrel—coronary artery disease	0.00397	0.0214	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Eplerenone—coronary artery disease	0.00369	0.0199	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Atorvastatin—coronary artery disease	0.00365	0.0197	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Losartan—coronary artery disease	0.00333	0.018	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Enalapril—coronary artery disease	0.00329	0.0178	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—cardial valve—coronary artery disease	0.00258	0.255	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—Ezetimibe—coronary artery disease	0.00256	0.0138	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Rosuvastatin—coronary artery disease	0.00256	0.0138	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Simvastatin—coronary artery disease	0.00238	0.0128	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Lovastatin—coronary artery disease	0.00233	0.0126	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Pravastatin—coronary artery disease	0.00233	0.0126	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Atorvastatin—coronary artery disease	0.00212	0.0114	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Losartan—coronary artery disease	0.00194	0.0105	CbGbCtD
Medroxyprogesterone Acetate—PGR—artery—coronary artery disease	0.000676	0.0668	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—cardiac ventricle—coronary artery disease	0.00056	0.0553	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—myocardium—coronary artery disease	0.000526	0.052	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—heart—coronary artery disease	0.000367	0.0363	CbGeAlD
Medroxyprogesterone Acetate—PGR—myocardium—coronary artery disease	0.000356	0.0352	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—cardiac atrium—coronary artery disease	0.000314	0.0311	CbGeAlD
Medroxyprogesterone Acetate—AR—cardiac ventricle—coronary artery disease	0.000302	0.0298	CbGeAlD
Medroxyprogesterone Acetate—AR—myocardium—coronary artery disease	0.000284	0.0281	CbGeAlD
Medroxyprogesterone Acetate—Eplerenone—CYP11B2—coronary artery disease	0.000277	0.16	CrCbGaD
Medroxyprogesterone Acetate—AKR1C3—blood—coronary artery disease	0.000274	0.0271	CbGeAlD
Medroxyprogesterone Acetate—SHBG—cardiovascular system—coronary artery disease	0.000261	0.0258	CbGeAlD
Medroxyprogesterone Acetate—PGR—heart—coronary artery disease	0.000249	0.0246	CbGeAlD
Medroxyprogesterone Acetate—PGR—cardiovascular system—coronary artery disease	0.000235	0.0232	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cardiac ventricle—coronary artery disease	0.000219	0.0216	CbGeAlD
Medroxyprogesterone Acetate—SHBG—blood—coronary artery disease	0.000206	0.0204	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—myocardium—coronary artery disease	0.000206	0.0203	CbGeAlD
Medroxyprogesterone Acetate—AR—heart—coronary artery disease	0.000198	0.0196	CbGeAlD
Medroxyprogesterone Acetate—Eplerenone—NR3C2—coronary artery disease	0.000196	0.113	CrCbGaD
Medroxyprogesterone Acetate—ESR1—heart—coronary artery disease	0.000195	0.0192	CbGeAlD
Medroxyprogesterone Acetate—Spironolactone—CYP11B2—coronary artery disease	0.000189	0.109	CrCbGaD
Medroxyprogesterone Acetate—Drospirenone—NR3C2—coronary artery disease	0.000188	0.109	CrCbGaD
Medroxyprogesterone Acetate—AR—cardiovascular system—coronary artery disease	0.000187	0.0185	CbGeAlD
Medroxyprogesterone Acetate—PGR—blood—coronary artery disease	0.000186	0.0184	CbGeAlD
Medroxyprogesterone Acetate—ESR1—cardiovascular system—coronary artery disease	0.000184	0.0182	CbGeAlD
Medroxyprogesterone Acetate—Fludrocortisone—NR3C2—coronary artery disease	0.000177	0.102	CrCbGaD
Medroxyprogesterone Acetate—AR—cardiac atrium—coronary artery disease	0.00017	0.0168	CbGeAlD
Medroxyprogesterone Acetate—AR—blood—coronary artery disease	0.000148	0.0146	CbGeAlD
Medroxyprogesterone Acetate—ESR1—blood—coronary artery disease	0.000145	0.0144	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—heart—coronary artery disease	0.000144	0.0142	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—heart—coronary artery disease	0.000142	0.0141	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cardiovascular system—coronary artery disease	0.000135	0.0134	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—cardiovascular system—coronary artery disease	0.000134	0.0133	CbGeAlD
Medroxyprogesterone Acetate—Spironolactone—NR3C2—coronary artery disease	0.000134	0.0773	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortisone—CYP11B2—coronary artery disease	0.000125	0.0724	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—cardiac atrium—coronary artery disease	0.000123	0.0121	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—blood—coronary artery disease	0.00012	0.0118	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—blood—coronary artery disease	0.000107	0.0106	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—blood—coronary artery disease	0.000106	0.0105	CbGeAlD
Medroxyprogesterone Acetate—Ethynodiol—ESR1—coronary artery disease	0.000101	0.0583	CrCbGaD
Medroxyprogesterone Acetate—CYP3A4—blood—coronary artery disease	8.1e-05	0.00801	CbGeAlD
Medroxyprogesterone Acetate—Progesterone—NR3C2—coronary artery disease	7.25e-05	0.0418	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—SLC22A3—coronary artery disease	5.06e-05	0.0292	CrCbGaD
Medroxyprogesterone Acetate—Fluoxymesterone—ESR1—coronary artery disease	5.02e-05	0.0289	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—SLC22A3—coronary artery disease	4.79e-05	0.0276	CrCbGaD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—coronary artery disease	3.22e-05	0.0186	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—ESR1—coronary artery disease	2.49e-05	0.0143	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—CYP2C19—coronary artery disease	1.99e-05	0.0115	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—CYP2C19—coronary artery disease	1.89e-05	0.0109	CrCbGaD
Medroxyprogesterone Acetate—Methyltestosterone—ALB—coronary artery disease	1.8e-05	0.0104	CrCbGaD
Medroxyprogesterone Acetate—Confusional state—Ramipril—coronary artery disease	1.63e-05	0.000181	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Timolol—coronary artery disease	1.63e-05	0.000181	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Niacin—coronary artery disease	1.62e-05	0.00018	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Losartan—coronary artery disease	1.62e-05	0.00018	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Ezetimibe—coronary artery disease	1.62e-05	0.00018	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Lisinopril—coronary artery disease	1.62e-05	0.00018	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Ramipril—coronary artery disease	1.61e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Ramipril—coronary artery disease	1.61e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Lisinopril—coronary artery disease	1.61e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Timolol—coronary artery disease	1.61e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Losartan—coronary artery disease	1.61e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Lisinopril—coronary artery disease	1.61e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Eplerenone—coronary artery disease	1.61e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Furosemide—coronary artery disease	1.61e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Fenofibrate—coronary artery disease	1.6e-05	0.000178	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Niacin—coronary artery disease	1.6e-05	0.000178	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Pravastatin—coronary artery disease	1.6e-05	0.000178	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Furosemide—coronary artery disease	1.59e-05	0.000177	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Eplerenone—coronary artery disease	1.59e-05	0.000177	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Perindopril—coronary artery disease	1.59e-05	0.000177	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Trandolapril—coronary artery disease	1.59e-05	0.000177	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Eplerenone—coronary artery disease	1.59e-05	0.000177	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Valsartan—coronary artery disease	1.59e-05	0.000177	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Timolol—coronary artery disease	1.59e-05	0.000177	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Ramipril—coronary artery disease	1.59e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Enalapril—coronary artery disease	1.59e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Perindopril—coronary artery disease	1.59e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Perindopril—coronary artery disease	1.59e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Lisinopril—coronary artery disease	1.58e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Olmesartan—coronary artery disease	1.58e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Eplerenone—coronary artery disease	1.58e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Ramipril—coronary artery disease	1.58e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Ramipril—coronary artery disease	1.58e-05	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Timolol—coronary artery disease	1.58e-05	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Timolol—coronary artery disease	1.58e-05	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Pravastatin—coronary artery disease	1.58e-05	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Lisinopril—coronary artery disease	1.58e-05	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Clopidogrel—coronary artery disease	1.57e-05	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Ramipril—coronary artery disease	1.57e-05	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Ramipril—coronary artery disease	1.57e-05	0.000174	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Timolol—coronary artery disease	1.57e-05	0.000174	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Simvastatin—coronary artery disease	1.57e-05	0.000174	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Telmisartan—coronary artery disease	1.57e-05	0.000174	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Lovastatin—coronary artery disease	1.56e-05	0.000174	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Ramipril—coronary artery disease	1.56e-05	0.000173	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Simvastatin—coronary artery disease	1.55e-05	0.000173	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Simvastatin—coronary artery disease	1.55e-05	0.000172	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Trandolapril—coronary artery disease	1.55e-05	0.000172	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Timolol—coronary artery disease	1.55e-05	0.000172	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Losartan—coronary artery disease	1.55e-05	0.000172	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Furosemide—coronary artery disease	1.55e-05	0.000172	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Niacin—coronary artery disease	1.55e-05	0.000172	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Timolol—coronary artery disease	1.55e-05	0.000172	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Enalapril—coronary artery disease	1.55e-05	0.000172	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Simvastatin—coronary artery disease	1.54e-05	0.000171	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Furosemide—coronary artery disease	1.54e-05	0.000171	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Furosemide—coronary artery disease	1.54e-05	0.000171	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Losartan—coronary artery disease	1.54e-05	0.000171	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Valsartan—coronary artery disease	1.54e-05	0.000171	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Ramipril—coronary artery disease	1.54e-05	0.000171	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Ezetimibe—coronary artery disease	1.53e-05	0.00017	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Timolol—coronary artery disease	1.53e-05	0.00017	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Olmesartan—coronary artery disease	1.53e-05	0.00017	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Trandolapril—coronary artery disease	1.53e-05	0.00017	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Lisinopril—coronary artery disease	1.53e-05	0.00017	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Lisinopril—coronary artery disease	1.53e-05	0.00017	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Lisinopril—coronary artery disease	1.53e-05	0.00017	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Timolol—coronary artery disease	1.52e-05	0.000169	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Telmisartan—coronary artery disease	1.52e-05	0.000169	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Enalapril—coronary artery disease	1.52e-05	0.000169	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Pravastatin—coronary artery disease	1.52e-05	0.000169	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Lisinopril—coronary artery disease	1.52e-05	0.000169	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	1.52e-05	0.000168	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Lisinopril—coronary artery disease	1.51e-05	0.000168	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Ramipril—coronary artery disease	1.51e-05	0.000167	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Timolol—coronary artery disease	1.5e-05	0.000167	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Telmisartan—coronary artery disease	1.5e-05	0.000167	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Eplerenone—coronary artery disease	1.5e-05	0.000167	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Niacin—coronary artery disease	1.5e-05	0.000166	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Losartan—coronary artery disease	1.49e-05	0.000166	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Lisinopril—coronary artery disease	1.49e-05	0.000166	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Losartan—coronary artery disease	1.49e-05	0.000165	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Losartan—coronary artery disease	1.49e-05	0.000165	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Captopril—coronary artery disease	1.48e-05	0.000165	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Trandolapril—coronary artery disease	1.48e-05	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Valsartan—coronary artery disease	1.48e-05	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Lisinopril—coronary artery disease	1.48e-05	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Enalapril—coronary artery disease	1.47e-05	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Timolol—coronary artery disease	1.47e-05	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Pravastatin—coronary artery disease	1.47e-05	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Olmesartan—coronary artery disease	1.47e-05	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Ramipril—coronary artery disease	1.47e-05	0.000163	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Valsartan—coronary artery disease	1.47e-05	0.000163	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Valsartan—coronary artery disease	1.47e-05	0.000163	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Simvastatin—coronary artery disease	1.46e-05	0.000163	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Lisinopril—coronary artery disease	1.46e-05	0.000163	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Lisinopril—coronary artery disease	1.46e-05	0.000163	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Captopril—coronary artery disease	1.46e-05	0.000162	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Olmesartan—coronary artery disease	1.46e-05	0.000162	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Ramipril—coronary artery disease	1.46e-05	0.000162	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Olmesartan—coronary artery disease	1.46e-05	0.000162	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Valsartan—coronary artery disease	1.46e-05	0.000162	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Telmisartan—coronary artery disease	1.45e-05	0.000161	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Lisinopril—coronary artery disease	1.45e-05	0.000161	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Olmesartan—coronary artery disease	1.45e-05	0.000161	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Ramipril—coronary artery disease	1.45e-05	0.000161	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Lisinopril—coronary artery disease	1.44e-05	0.00016	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Perindopril—coronary artery disease	1.44e-05	0.00016	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Ramipril—coronary artery disease	1.44e-05	0.00016	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Niacin—coronary artery disease	1.44e-05	0.00016	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Timolol—coronary artery disease	1.44e-05	0.00016	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Furosemide—coronary artery disease	1.44e-05	0.00016	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Ramipril—coronary artery disease	1.43e-05	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Lisinopril—coronary artery disease	1.43e-05	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Trandolapril—coronary artery disease	1.43e-05	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Lisinopril—coronary artery disease	1.43e-05	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Timolol—coronary artery disease	1.43e-05	0.000158	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Niacin—coronary artery disease	1.43e-05	0.000158	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Niacin—coronary artery disease	1.42e-05	0.000158	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Enalapril—coronary artery disease	1.42e-05	0.000158	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Lisinopril—coronary artery disease	1.42e-05	0.000158	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Ramipril—coronary artery disease	1.42e-05	0.000158	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Perindopril—coronary artery disease	1.42e-05	0.000158	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Niacin—coronary artery disease	1.42e-05	0.000157	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Timolol—coronary artery disease	1.42e-05	0.000157	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Pravastatin—coronary artery disease	1.42e-05	0.000157	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Lisinopril—coronary artery disease	1.41e-05	0.000157	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Captopril—coronary artery disease	1.41e-05	0.000157	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Timolol—coronary artery disease	1.41e-05	0.000156	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Telmisartan—coronary artery disease	1.4e-05	0.000156	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Pravastatin—coronary artery disease	1.4e-05	0.000156	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Pravastatin—coronary artery disease	1.4e-05	0.000156	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Ramipril—coronary artery disease	1.4e-05	0.000156	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Timolol—coronary artery disease	1.4e-05	0.000156	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Furosemide—coronary artery disease	1.4e-05	0.000155	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Pravastatin—coronary artery disease	1.39e-05	0.000155	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Lisinopril—coronary artery disease	1.39e-05	0.000155	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Ramipril—coronary artery disease	1.39e-05	0.000155	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Ramipril—coronary artery disease	1.39e-05	0.000155	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Timolol—coronary artery disease	1.39e-05	0.000154	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Losartan—coronary artery disease	1.39e-05	0.000154	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Valsartan—coronary artery disease	1.38e-05	0.000154	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Furosemide—coronary artery disease	1.38e-05	0.000153	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Ramipril—coronary artery disease	1.38e-05	0.000153	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Olmesartan—coronary artery disease	1.37e-05	0.000153	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Trandolapril—coronary artery disease	1.37e-05	0.000153	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Perindopril—coronary artery disease	1.37e-05	0.000152	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Timolol—coronary artery disease	1.37e-05	0.000152	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Enalapril—coronary artery disease	1.37e-05	0.000152	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Lisinopril—coronary artery disease	1.37e-05	0.000152	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Captopril—coronary artery disease	1.37e-05	0.000152	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Trandolapril—coronary artery disease	1.36e-05	0.000151	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Trandolapril—coronary artery disease	1.36e-05	0.000151	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Timolol—coronary artery disease	1.36e-05	0.000151	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Timolol—coronary artery disease	1.36e-05	0.000151	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Enalapril—coronary artery disease	1.36e-05	0.000151	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Enalapril—coronary artery disease	1.36e-05	0.000151	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Trandolapril—coronary artery disease	1.35e-05	0.000151	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Telmisartan—coronary artery disease	1.35e-05	0.00015	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Losartan—coronary artery disease	1.35e-05	0.00015	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Enalapril—coronary artery disease	1.35e-05	0.00015	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Niacin—coronary artery disease	1.34e-05	0.000149	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Telmisartan—coronary artery disease	1.34e-05	0.000149	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Telmisartan—coronary artery disease	1.34e-05	0.000149	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Furosemide—coronary artery disease	1.33e-05	0.000148	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.33e-05	0.000148	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Losartan—coronary artery disease	1.33e-05	0.000148	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Telmisartan—coronary artery disease	1.33e-05	0.000148	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Ramipril—coronary artery disease	1.33e-05	0.000148	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Perindopril—coronary artery disease	1.33e-05	0.000147	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Lisinopril—coronary artery disease	1.32e-05	0.000147	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Pravastatin—coronary artery disease	1.32e-05	0.000147	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Ramipril—coronary artery disease	1.32e-05	0.000147	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Lisinopril—coronary artery disease	1.31e-05	0.000146	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Captopril—coronary artery disease	1.31e-05	0.000146	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Lisinopril—coronary artery disease	1.3e-05	0.000145	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Captopril—coronary artery disease	1.3e-05	0.000145	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Captopril—coronary artery disease	1.3e-05	0.000145	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Lisinopril—coronary artery disease	1.3e-05	0.000144	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Timolol—coronary artery disease	1.3e-05	0.000144	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Captopril—coronary artery disease	1.29e-05	0.000144	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Timolol—coronary artery disease	1.29e-05	0.000143	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Furosemide—coronary artery disease	1.29e-05	0.000143	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Lisinopril—coronary artery disease	1.29e-05	0.000143	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Losartan—coronary artery disease	1.29e-05	0.000143	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Trandolapril—coronary artery disease	1.28e-05	0.000143	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Ramipril—coronary artery disease	1.28e-05	0.000142	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Enalapril—coronary artery disease	1.28e-05	0.000142	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Perindopril—coronary artery disease	1.28e-05	0.000142	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Ramipril—coronary artery disease	1.28e-05	0.000142	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Ramipril—coronary artery disease	1.28e-05	0.000142	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Lisinopril—coronary artery disease	1.27e-05	0.000141	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Perindopril—coronary artery disease	1.26e-05	0.00014	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Perindopril—coronary artery disease	1.26e-05	0.00014	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.26e-05	0.00014	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Telmisartan—coronary artery disease	1.26e-05	0.00014	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Lisinopril—coronary artery disease	1.26e-05	0.00014	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Perindopril—coronary artery disease	1.26e-05	0.00014	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Timolol—coronary artery disease	1.25e-05	0.000139	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Lisinopril—coronary artery disease	1.25e-05	0.000139	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Timolol—coronary artery disease	1.25e-05	0.000138	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Timolol—coronary artery disease	1.25e-05	0.000138	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Losartan—coronary artery disease	1.24e-05	0.000138	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Furosemide—coronary artery disease	1.24e-05	0.000138	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Furosemide—coronary artery disease	1.23e-05	0.000137	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Furosemide—coronary artery disease	1.23e-05	0.000136	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Captopril—coronary artery disease	1.23e-05	0.000136	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Furosemide—coronary artery disease	1.22e-05	0.000136	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Lisinopril—coronary artery disease	1.21e-05	0.000134	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Lisinopril—coronary artery disease	1.2e-05	0.000133	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Losartan—coronary artery disease	1.2e-05	0.000133	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Perindopril—coronary artery disease	1.19e-05	0.000132	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Ramipril—coronary artery disease	1.19e-05	0.000132	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Losartan—coronary artery disease	1.19e-05	0.000132	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Losartan—coronary artery disease	1.19e-05	0.000132	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Losartan—coronary artery disease	1.18e-05	0.000131	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Lisinopril—coronary artery disease	1.16e-05	0.000129	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Timolol—coronary artery disease	1.16e-05	0.000129	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Furosemide—coronary artery disease	1.16e-05	0.000129	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Ramipril—coronary artery disease	1.16e-05	0.000129	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Lisinopril—coronary artery disease	1.16e-05	0.000128	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Lisinopril—coronary artery disease	1.16e-05	0.000128	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Ramipril—coronary artery disease	1.14e-05	0.000127	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Timolol—coronary artery disease	1.13e-05	0.000126	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Losartan—coronary artery disease	1.12e-05	0.000124	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Timolol—coronary artery disease	1.12e-05	0.000124	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Ramipril—coronary artery disease	1.1e-05	0.000123	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Timolol—coronary artery disease	1.08e-05	0.00012	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Lisinopril—coronary artery disease	1.08e-05	0.00012	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Ramipril—coronary artery disease	1.07e-05	0.000119	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Lisinopril—coronary artery disease	1.05e-05	0.000117	CcSEcCtD
Medroxyprogesterone Acetate—Testosterone—ALB—coronary artery disease	1.05e-05	0.00603	CrCbGaD
Medroxyprogesterone Acetate—Dizziness—Timolol—coronary artery disease	1.04e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Lisinopril—coronary artery disease	1.03e-05	0.000115	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Ramipril—coronary artery disease	1.03e-05	0.000114	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Ramipril—coronary artery disease	1.02e-05	0.000113	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Ramipril—coronary artery disease	1.02e-05	0.000113	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Ramipril—coronary artery disease	1.01e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Timolol—coronary artery disease	1e-05	0.000111	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Lisinopril—coronary artery disease	1e-05	0.000111	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Timolol—coronary artery disease	9.94e-06	0.00011	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Timolol—coronary artery disease	9.93e-06	0.00011	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Timolol—coronary artery disease	9.88e-06	0.00011	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Lisinopril—coronary artery disease	9.67e-06	0.000107	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Ramipril—coronary artery disease	9.58e-06	0.000106	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Timolol—coronary artery disease	9.37e-06	0.000104	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Lisinopril—coronary artery disease	9.3e-06	0.000103	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Lisinopril—coronary artery disease	9.22e-06	0.000102	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Lisinopril—coronary artery disease	9.22e-06	0.000102	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Lisinopril—coronary artery disease	9.16e-06	0.000102	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Lisinopril—coronary artery disease	8.69e-06	9.65e-05	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—P4HB—coronary artery disease	1.95e-06	4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PRKCE—coronary artery disease	1.93e-06	3.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SOCS1—coronary artery disease	1.93e-06	3.96e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.93e-06	3.96e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SDC1—coronary artery disease	1.93e-06	3.96e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—S100B—coronary artery disease	1.92e-06	3.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	1.91e-06	3.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PPARG—coronary artery disease	1.91e-06	3.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SOCS3—coronary artery disease	1.9e-06	3.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCND1—coronary artery disease	1.9e-06	3.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SERPINE1—coronary artery disease	1.9e-06	3.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.89e-06	3.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.89e-06	3.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFBR2—coronary artery disease	1.88e-06	3.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KITLG—coronary artery disease	1.88e-06	3.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PPARG—coronary artery disease	1.88e-06	3.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.87e-06	3.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PIK3CA—coronary artery disease	1.85e-06	3.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—coronary artery disease	1.85e-06	3.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FGF2—coronary artery disease	1.84e-06	3.78e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP3—coronary artery disease	1.84e-06	3.78e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—STAT5A—coronary artery disease	1.84e-06	3.78e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PSMA6—coronary artery disease	1.82e-06	3.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PSMB5—coronary artery disease	1.82e-06	3.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.82e-06	3.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOS3—coronary artery disease	1.82e-06	3.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.8e-06	3.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HK2—coronary artery disease	1.8e-06	3.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—VCAN—coronary artery disease	1.8e-06	3.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALDOA—coronary artery disease	1.79e-06	3.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CTGF—coronary artery disease	1.78e-06	3.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOB—coronary artery disease	1.78e-06	3.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—JAK2—coronary artery disease	1.76e-06	3.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HMGCR—coronary artery disease	1.76e-06	3.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GOT2—coronary artery disease	1.76e-06	3.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EDN1—coronary artery disease	1.75e-06	3.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL5—coronary artery disease	1.74e-06	3.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—DCN—coronary artery disease	1.73e-06	3.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.73e-06	3.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SERPINE1—coronary artery disease	1.72e-06	3.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CSF2—coronary artery disease	1.71e-06	3.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGF1—coronary artery disease	1.71e-06	3.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LPL—coronary artery disease	1.7e-06	3.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.69e-06	3.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LCAT—coronary artery disease	1.69e-06	3.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SERPINE1—coronary artery disease	1.69e-06	3.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALDH2—coronary artery disease	1.69e-06	3.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RPS6KB1—coronary artery disease	1.68e-06	3.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MEF2C—coronary artery disease	1.68e-06	3.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOA4—coronary artery disease	1.66e-06	3.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—coronary artery disease	1.66e-06	3.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.64e-06	3.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HBA1—coronary artery disease	1.64e-06	3.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	1.64e-06	3.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—LIPC—coronary artery disease	1.64e-06	3.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP2C19—coronary artery disease	1.64e-06	3.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ITGB3—coronary artery disease	1.64e-06	3.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—coronary artery disease	1.64e-06	3.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOC3—coronary artery disease	1.63e-06	3.36e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—LDLR—coronary artery disease	1.62e-06	3.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.62e-06	3.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PLCB1—coronary artery disease	1.62e-06	3.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL8—coronary artery disease	1.61e-06	3.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.6e-06	3.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GCLM—coronary artery disease	1.6e-06	3.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTT1—coronary artery disease	1.6e-06	3.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC9A1—coronary artery disease	1.6e-06	3.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PPP2CA—coronary artery disease	1.59e-06	3.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.59e-06	3.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GCLC—coronary artery disease	1.59e-06	3.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CETP—coronary artery disease	1.59e-06	3.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ABCA1—coronary artery disease	1.57e-06	3.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SDC1—coronary artery disease	1.57e-06	3.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PRKCD—coronary artery disease	1.56e-06	3.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.55e-06	3.19e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.55e-06	3.19e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PIK3CA—coronary artery disease	1.55e-06	3.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CASP3—coronary artery disease	1.54e-06	3.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.53e-06	3.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR2A—coronary artery disease	1.53e-06	3.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—C3—coronary artery disease	1.53e-06	3.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—coronary artery disease	1.52e-06	3.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GOT1—coronary artery disease	1.52e-06	3.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GGT1—coronary artery disease	1.52e-06	3.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AKT1—coronary artery disease	1.51e-06	3.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.51e-06	3.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HADH—coronary artery disease	1.51e-06	3.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCND1—coronary artery disease	1.5e-06	3.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK1—coronary artery disease	1.49e-06	3.07e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PSMA6—coronary artery disease	1.48e-06	3.04e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PSMB5—coronary artery disease	1.48e-06	3.04e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.48e-06	3.04e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HIF1A—coronary artery disease	1.46e-06	2.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—coronary artery disease	1.46e-06	2.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AGT—coronary artery disease	1.45e-06	2.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CTGF—coronary artery disease	1.45e-06	2.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GOT2—coronary artery disease	1.43e-06	2.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HMGCR—coronary artery disease	1.43e-06	2.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPX2—coronary artery disease	1.43e-06	2.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.43e-06	2.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOA2—coronary artery disease	1.43e-06	2.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOE—coronary artery disease	1.42e-06	2.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LEP—coronary artery disease	1.42e-06	2.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPX4—coronary artery disease	1.41e-06	2.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.41e-06	2.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HK1—coronary artery disease	1.41e-06	2.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.41e-06	2.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOA1—coronary artery disease	1.41e-06	2.89e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HADHA—coronary artery disease	1.4e-06	2.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KDR—coronary artery disease	1.39e-06	2.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK14—coronary artery disease	1.38e-06	2.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.38e-06	2.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTP1—coronary artery disease	1.37e-06	2.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LPA—coronary artery disease	1.36e-06	2.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	1.35e-06	2.78e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HMOX1—coronary artery disease	1.35e-06	2.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FN1—coronary artery disease	1.34e-06	2.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—F2—coronary artery disease	1.34e-06	2.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6ST—coronary artery disease	1.34e-06	2.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CAT—coronary artery disease	1.33e-06	2.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NFKBIA—coronary artery disease	1.33e-06	2.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.32e-06	2.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PLCB1—coronary artery disease	1.32e-06	2.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOA5—coronary artery disease	1.31e-06	2.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—coronary artery disease	1.31e-06	2.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PIK3CA—coronary artery disease	1.3e-06	2.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.29e-06	2.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOB—coronary artery disease	1.29e-06	2.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KIT—coronary artery disease	1.28e-06	2.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—AKT1—coronary artery disease	1.28e-06	2.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—P4HB—coronary artery disease	1.28e-06	2.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ABCA1—coronary artery disease	1.28e-06	2.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AKT1—coronary artery disease	1.27e-06	2.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.26e-06	2.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTM1—coronary artery disease	1.26e-06	2.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GGT1—coronary artery disease	1.24e-06	2.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GOT1—coronary artery disease	1.24e-06	2.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—LPL—coronary artery disease	1.23e-06	2.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GSK3B—coronary artery disease	1.23e-06	2.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—POMC—coronary artery disease	1.22e-06	2.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CREB1—coronary artery disease	1.22e-06	2.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GPX1—coronary artery disease	1.2e-06	2.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—coronary artery disease	1.2e-06	2.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL2—coronary artery disease	1.2e-06	2.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6R—coronary artery disease	1.19e-06	2.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—VCAN—coronary artery disease	1.19e-06	2.44e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.18e-06	2.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK1—coronary artery disease	1.18e-06	2.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1—coronary artery disease	1.18e-06	2.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CD36—coronary artery disease	1.17e-06	2.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPP2CA—coronary artery disease	1.16e-06	2.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—coronary artery disease	1.15e-06	2.36e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—DCN—coronary artery disease	1.14e-06	2.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SERPINE1—coronary artery disease	1.12e-06	2.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.11e-06	2.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.11e-06	2.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MTHFR—coronary artery disease	1.11e-06	2.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.1e-06	2.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.1e-06	2.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HBA1—coronary artery disease	1.08e-06	2.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LIPC—coronary artery disease	1.08e-06	2.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.08e-06	2.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.08e-06	2.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CAT—coronary artery disease	1.08e-06	2.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGF2—coronary artery disease	1.08e-06	2.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOC3—coronary artery disease	1.08e-06	2.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LDLR—coronary artery disease	1.07e-06	2.2e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOS3—coronary artery disease	1.07e-06	2.19e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.06e-06	2.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.06e-06	2.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AKT1—coronary artery disease	1.06e-06	2.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AGT—coronary artery disease	1.05e-06	2.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOB—coronary artery disease	1.05e-06	2.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GCLC—coronary artery disease	1.05e-06	2.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CETP—coronary artery disease	1.05e-06	2.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—JAK2—coronary artery disease	1.04e-06	2.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SDC1—coronary artery disease	1.03e-06	2.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOE—coronary artery disease	1.03e-06	2.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.02e-06	2.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CA—coronary artery disease	1.02e-06	2.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOA1—coronary artery disease	1.02e-06	2.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—LPL—coronary artery disease	1e-06	2.06e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GPX1—coronary artery disease	9.79e-07	2.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—AKT1—coronary artery disease	9.78e-07	2.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	9.78e-07	2.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PSMB5—coronary artery disease	9.77e-07	2.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PSMA6—coronary artery disease	9.77e-07	2.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CTGF—coronary artery disease	9.54e-07	1.96e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CD36—coronary artery disease	9.53e-07	1.96e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HMGCR—coronary artery disease	9.46e-07	1.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GOT2—coronary artery disease	9.46e-07	1.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL8—coronary artery disease	9.45e-07	1.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPP2CA—coronary artery disease	9.41e-07	1.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CASP3—coronary artery disease	9.05e-07	1.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—coronary artery disease	9.05e-07	1.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MTHFR—coronary artery disease	9.03e-07	1.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARG—coronary artery disease	9e-07	1.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—POMC—coronary artery disease	8.88e-07	1.82e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCND1—coronary artery disease	8.81e-07	1.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLCB1—coronary artery disease	8.7e-07	1.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AGT—coronary artery disease	8.58e-07	1.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—coronary artery disease	8.55e-07	1.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCA1—coronary artery disease	8.43e-07	1.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOE—coronary artery disease	8.41e-07	1.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKT1—coronary artery disease	8.35e-07	1.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOA1—coronary artery disease	8.31e-07	1.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GGT1—coronary artery disease	8.16e-07	1.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GOT1—coronary artery disease	8.16e-07	1.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALB—coronary artery disease	8.09e-07	1.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.96e-07	1.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NOS3—coronary artery disease	7.74e-07	1.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—coronary artery disease	7.68e-07	1.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—AKT1—coronary artery disease	7.53e-07	1.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—AKT1—coronary artery disease	7.42e-07	1.52e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTP1—coronary artery disease	7.33e-07	1.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARG—coronary artery disease	7.32e-07	1.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	7.27e-07	1.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HMOX1—coronary artery disease	7.23e-07	1.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—POMC—coronary artery disease	7.22e-07	1.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CAT—coronary artery disease	7.14e-07	1.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—coronary artery disease	7.08e-07	1.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—coronary artery disease	7.05e-07	1.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOB—coronary artery disease	6.93e-07	1.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK1—coronary artery disease	6.91e-07	1.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTM1—coronary artery disease	6.74e-07	1.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LPL—coronary artery disease	6.62e-07	1.36e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALB—coronary artery disease	6.59e-07	1.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPX1—coronary artery disease	6.45e-07	1.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NOS3—coronary artery disease	6.3e-07	1.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CD36—coronary artery disease	6.29e-07	1.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPP2CA—coronary artery disease	6.21e-07	1.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CA—coronary artery disease	6e-07	1.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MTHFR—coronary artery disease	5.96e-07	1.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—coronary artery disease	5.76e-07	1.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AGT—coronary artery disease	5.66e-07	1.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOE—coronary artery disease	5.55e-07	1.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOA1—coronary artery disease	5.48e-07	1.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—coronary artery disease	5.31e-07	1.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT1—coronary artery disease	4.9e-07	1.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARG—coronary artery disease	4.83e-07	9.93e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—POMC—coronary artery disease	4.76e-07	9.79e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CA—coronary artery disease	4.36e-07	8.95e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALB—coronary artery disease	4.34e-07	8.92e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NOS3—coronary artery disease	4.15e-07	8.54e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.8e-07	7.81e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKT1—coronary artery disease	3.56e-07	7.31e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CA—coronary artery disease	3.54e-07	7.28e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKT1—coronary artery disease	2.9e-07	5.95e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.34e-07	4.8e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKT1—coronary artery disease	1.91e-07	3.92e-06	CbGpPWpGaD
